Precision Cancer Biology: From Targeted to Immune Therapies

We are pleased to announce the Cold Spring Harbor Asia conference on Precision Cancer Biology: From Targeted to Immune Therapies which will be held in Suzhou, China, located approximately 60 miles west of Shanghai. The conference will begin at 7:00pm on the evening of Monday September 18, and will conclude after lunch on September 22, 2017.

The conference will include eight oral sessions and one poster session covering the latest findings across many topics in cancer biology. Many talks will be selected from the openly submitted abstracts on the basis of scientific merit and relevance. Social events throughout the conference provide ample opportunity for informal interactions.

Major Topics: 
1. Tumor immunology and immunotherapy 
2. Cancer genomics and targeted therapy
3. Cancer stem cells
4. Cancer pathways
5. Tumor metastasis
6. New technologies and large-scale cancer biology 

Keynote Speakers:
James Allison, The University of Texas MD Anderson Cancer Center, USA

Confirmed Speakers:
Hiroyuki Aburatani, University of Tokyo, Japan
Priscilla Brastianos, Dana-Farber/Harvard Cancer Center, USA 
Frederic De Sauvage, Genentech, Inc., USA
Chen Dong, Tsinghua University, CHINA
Yang-Xin Fu, UT Southwestern Medical Center, USA
Thomas Gajewski, University of Chicago, Medical School, USA
Jerome Galon, INSERM U872, Cordeliers Research Center, FRANCE
Philip Greenberg, Fred Hutchinson Cancer Research Center, USA
Hongbin Ji, Institute of Biochemistry & Cell Biology, SIBS, CAS, CHINA
Kazuhiro Kakimi, The University of Tokyo, JAPAN
Raghu Kalluri, MD Anderson Cancer Center, USA
Michael Karin, University of California, San Diego, USA
Yutaka Kawakami, Keio University School of Medicine, JAPAN
Vijay Kuchroo, Harvard Medical School, USA
Xiaole Shirley Liu, Dana-Farber Cancer Institute, Harvard University, USA 
Flavius Martin, Amgen, USA
Tak Mak, Ontario Cancer Institute, CANADA 
Satoru Miyano, University of Tokyo, JAPAN
Hidewaki Nakagawa, RIKEN Center for Integrative Medical Science, JAPAN
Seishi Ogawa, Kyoto University, Graduate School of Medicine, JAPAN
Wenjun Ouyang, Amgen, USA
Somasekar Seshagiri, Genentech Inc, USA
Padmanee Sharma, The University of Texas MD Anderson Cancer Center, USA
Arlene Sharpe, Harvard Medical School, USA
Tatsuhiro Shibata, National Cancer Center Research Institute, JAPAN
Ramesh Shivdasani, Harvard Medical School Dana-Farber Cancer Institute, USA
Patrick Tan, Duke-NUS Medical School, SINGAPORE
Hong Wu, Peking University, CHINA
Xiaoliang Sunney Xie, Harvard University, USA
Chengcheng (Alec) Zhang, UT Southwestern Medical Center, USA
Pan Zheng, Children's National Health System, USA
Xingxing Zang, Albert Einstein College of Medicine, USA
Zemin Zhang, Peking University, CHINA

We encourage abstracts to contain new and unpublished materials. The abstracts must be submitted electronically by the abstract deadline. Selection of material for oral and poster presentation will be made by the organizers. Status (fellow's talk/poster) of abstracts will be posted on our web site as soon as decisions have been made by the organizers.


Fellowship: 
We are eager to have as many young people as possible attend since they are likely to benefit most from this meeting. A certain number of presentations by graduate students and postdocs in this conference will be selected as fellowship (USD $100-$500) awards. For more details, please visit http://www.csh-asia.org/stipends.html

We look forward to seeing you at Suzhou in September, 2017.